Cancer mortality: in the urology department of CHU Gabriel Touré

The aim was to study morality due to urological cancer in the urology department of CHU Gabriel Touré during the study period.Material and methods: We carried out a retrospective cross-sectional study Descriptive in the urology department of CHU Gabriel Touré during the period January 1, 2021 to December 31, 2024, a 4-year period. During the study period, we collected 37 records of patients who died of urological cancer from 1077 hospitalized patients. This corresponds to an overall mortality rate of 3.4%. Of these 37 deaths, 27 were due to urogenital cancer, representing a cancer mortality rate of 72.9%.Hematuria was the most frequent reason for consultation, at 48.1%. Among patients, 85.1% had anemia, including 18.5% with a hemoglobin level below 6 g/dl, 44.4% with a level between 6 and 7 g/dl, and 22.2% with a level between 8 and 9 g/dl.During our study period, 92.6% of patients who died of urogenital cancer were limited to receiving palliative treatment due to the advanced stage of their cancer.